These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1549216

  • 1. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism.
    Schwarz J, Tatsch K, Arnold G, Gasser T, Trenkwalder C, Kirsch CM, Oertel WH.
    Neurology; 1992 Mar; 42(3 Pt 1):556-61. PubMed ID: 1549216
    [Abstract] [Full Text] [Related]

  • 2. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
    Schwarz J, Tatsch K, Arnold G, Ott M, Trenkwalder C, Kirsch CM, Oertel WH.
    Neurology; 1993 Dec; 43(12 Suppl 6):S17-20. PubMed ID: 8264906
    [Abstract] [Full Text] [Related]

  • 3. 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism.
    Schwarz J, Tatsch K, Gasser T, Arnold G, Pogarell O, Künig G, Oertel WH.
    Mov Disord; 1998 Jan; 13(1):16-9. PubMed ID: 9452320
    [Abstract] [Full Text] [Related]

  • 4. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Schwarz J, Tatsch K, Gasser T, Arnold G, Oertel WH.
    Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212
    [Abstract] [Full Text] [Related]

  • 5. IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.
    Oertel WH, Schwarz J, Tatsch K, Arnold G, Gasser T, Kirsch CM.
    Adv Neurol; 1993 Nov; 60():519-24. PubMed ID: 8420182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W.
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [Abstract] [Full Text] [Related]

  • 8. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
    van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG.
    Arch Neurol; 1993 May; 50(5):513-6. PubMed ID: 8489409
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G, Gratz KF, Kolbe H, Meyer GJ, Dengler R, Knoop BO, Hundeshagen H.
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [Abstract] [Full Text] [Related]

  • 14. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J, Castelli L, Cordes M, Schelosky L, Poewe W, Felix R.
    Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T, Podreka I, Angelberger P, Wenger S, Topitz A, Küfferle B, Müller C, Deecke L.
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [Abstract] [Full Text] [Related]

  • 16. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R.
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [Abstract] [Full Text] [Related]

  • 17. Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.
    Pizzolato G, Chierichetti F, Rossato A, Briani C, Dam M, Borsato N, Saitta B, Zanco P, Ferlin G, Battistin L.
    Eur Neurol; 1993 Jun; 33(2):143-8. PubMed ID: 8467821
    [Abstract] [Full Text] [Related]

  • 18. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.
    Tatsch K, Schwarz J, Oertel WH, Kirsch CM.
    Nucl Med Commun; 1991 Aug; 12(8):699-707. PubMed ID: 1838142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.